Combined seton placement, infliximab infusion, and maintenance immunosuppressives improve healing rate in fistulizing anorectal Crohn's disease: A single center experience

Diseases of the Colon and Rectum

Volumn 46, Issue 5, 2003, Pages 577-583

  Topstad, Dawnelle R ^a   Panaccione, Remo ^a   Heine, John A ^a   Johnson, Douglas R E ^a   MacLean, Anthony R ^a   Buie, W Donald ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Anal Crohn's disease; Infliximab; Perianal fistula

Indexed keywords

AZATHIOPRINE; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE;

ABSCESS; ADOLESCENT; ADULT; ALGORITHM; ANORECTAL FISTULA; ANUS FISTULA; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CROHN DISEASE; DRUG EFFICACY; DYSPNEA; FEMALE; FEVER; FISTULA; FOLLOW UP; HUMAN; HYPOTENSION; IMMUNOSUPPRESSIVE TREATMENT; MALE; RASH; RECTOVAGINAL FISTULA; RETROSPECTIVE STUDY; SCROTUM DISORDER; SURGICAL DRAINAGE; THORAX PAIN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; ANTIBODIES, MONOCLONAL; COMBINED MODALITY THERAPY; CROHN DISEASE; DIGESTIVE SYSTEM SURGICAL PROCEDURES; DRAINAGE; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; RECTAL FISTULA; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; WOUND HEALING;

EID: 0037954147     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10350-004-6611-4     Document Type: Article

References (22)

1. Schwartz DA, Loftus EV, Tremaine WJ, et al. The natural history of fistulizing Crohn's disease in Olmsted County, Minnesota. Gastroenterology 2002;122:875-80.
2. Present DH, Rutgeerts P, Targan S, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-1405.
3. Ursing B, Kamme C. Metronidazole for Crohn's disease. Lancet 1975;1:775-7.
4. Bernstein LH, Frank MS, Brandt LJ, Boley SJ. Healing of perineal Crohn's disease with Metronidazole. Gastroenterology 1980;79:357-65.
5. Brandt LJ, Bernstein LH, Boley SJ, Frank MS. Metronidazole therapy for perineal Crohn's disease: a follow-up study. Gastroenterology 1982;83:383-7.
6. Jakobovits J, Schuster MM. Metronidazole therapy for Crohn's disease and associated fistulae. Am J Gastroenterol 1984;79:533-40.
7. Rhodes J, Bainton D, Beck P, Campbell H. Controlled trial of azathioprine in Crohn's disease. Lancet. 1971;2:1273-6.
8. Korelitz BI, Present DH. Favorable effect of 6-mercaptopurine on fistulae of Crohn's disease. Dig Dis Sci 1985;30:58-64.
9. Markowitz J, Rosa J, Grancher K, Aiges H, Daum F. Long-term 6-mercaptopurine treatment in adolescents with Crohn's disease. Gastroenterology 1990;99: 1347-51.
10. Present DH, Korelitz BI, Wisch N, Glass JL, Sachar DB, Pasternack BS. Treatment of Crohn's disease with 6-mercaptopurine. A long-term, randomized, doubleblind study. N Engl J Med 1980;302:981-7.
11. Present DH, Lichtiger S. Efficacy of Cycolsporine in treatment of fistula of Crohn's disease. Dig Dis Sci 1994; 39:374-80.
12. Hanauer SB, Smith MB. Rapid closure of Crohn's disease fistulas with continuous intravenous Cyclosporine A. Am J Gastroenterol 1993;88:646-9.
13. Lowry PW, Weaver AL, Tremaine WJ, Sandborn WJ. Combination therapy with oral tacrolimus (FK506) and azathioprine or 6-mercaptopurine for treatment refractory Crohn's disease perianal fistulae. Inflamm Bowel Dis 1999;5:239-45.
14. Bayer I, Gordon PH. Selected operative management of fistula-in-ano in Crohn's disease. Dis Colon Rectum 1994;37:760-5.
15. Cohen RD, Tsang JF, Hanauer SB. Infliximab in Crohn's disease: first anniversary clinical experience. Am J Gastroenterol 2000;95:3469-77.
16. Sample C, Bailey RJ, Todoruk D, et al. Clinical experience with infliximab for Crohn's disease: the first 100 patients in Edmonton, Alberta. Can J Gastroenterol 2002;16:165-70.
17. Arnott ID, McDonald D, Williams A, Ghosh S. Clinical use of Infliximab in Crohn's disease: the Edinburgh experience. Aliment Pharmacol Ther 2001;15:1639-46.
18. Ricart E, Panaccione R, Loftus EV, Tremaine WJ, Sandborn WJ. Infliximab for Crohn's disease in clinical practice at the Mayo Clinic: the first 100 patients. Am J Gastroenterol 2001;96:722-9.
19. Farrell RJ, Shah SA, Lodhavia PJ, et al. Clinical experience with infliximab therapy in 100 patients with Crohn's disease. Am J Gastroenterol 2000;95:3490-7.
20. van Bodegraven AA, Sloots CE, Felt-Bersma RJ, Meuwissen SG. Endosonographic evidence of persistence of Crohn's disease-associated fistulas after infliximab treatment, irrespective of clinical response. Dis Colon Rectum 2002;45:39-45.
21. Schaible TF. Long term safety of infliximab. Can J Gastroenterol 2000;14Suppl C:29C-32C.
22. Ky A, Sohn N, Weinstein MA, Korelitz BI. Carcinoma arising in anorectal fistulas of Crohn's disease. Dis Colon Rectum 1998;41:992-6.